|
|
|
Pluristem Therapeutc 
|
7.08 -0.22 (-0.03%) |
01-27 16:00 |
Open: |
7.17 |
Pre close: |
7.3 |
Target:
|
9.81
|
High: |
7.43 |
Low: |
6.8 |
Resistance:
|
8.40
9.89
|
Volume: |
498,264 |
Market Cap: |
181M |
Support:
|
5.98
4.98
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
7.35
 |
MACD |
MACD(12,26):
|
-0.11  |
MA(20): |
7.56  |
Signal(12,26,9): |
-0.09  |
MA(100): |
9.01  |
Stochastic Oscillator |
%K(14,3):
|
13.28  |
MA(250): |
7.97  |
%D(3): |
16.94  |
Average Volume(K) |
3-Month: |
66565
|
52-Week |
High:
|
13.29 |
10-Days: |
78891 |
Low: |
2.82 |
RSI |
RSI(14):
|
41.45  |
Change(%): |
88.3 |
Financials, Statistics and Valuation |
EPS |
-1.470 |
Return on Equity (ttm) |
-91.8 |
Shares Out. (M) |
25.63 |
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-44.8 |
Shares Float (M) |
18.00 |
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.94 |
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.64 |
Forward EPS |
-2.900 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
1070 |
Book Value (p.s.) |
1.910 |
EBITDA (p.s.) |
-1.154 |
P/E |
-4.82 |
Sales Per Share |
0.001 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.71 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.27 |
P/S |
7889.58 |
Operating Margin |
-134860.88 |
Levered Free Cash Flow
(M) |
-14.52 |
P/CF |
-7.18 |
|
|
|
|
|